Letter of Intent and further purchase orders

    RNS Number : 4668J
  Oxonica plc
  03 December 2008
   

    
    3 December 2008
    Oxonica plc
     Letter of Intent and further purchase orders for Security Business
    Oxonica Materials Inc., a wholly-owned US subsidiary of Oxonica plc, a leading nanomaterials group, announces receipt of a letter of
intent for three purchases of anti-counterfeiting development products totalling $3,964,000 between now and 1 October 2009. The first of
these purchase orders, received on 24 November 2008, totals $1,389,000. Completion of these orders is part of a continuing project with an
existing customer of Oxonica's security business, which will bring the total revenue from this client to over US $9 million since November
2005.
    Oxonica Materials Inc. develops covert brand and product security solutions based on proprietary, patented nanomaterials. The worldwide
addressable market for this anti-counterfeiting technology is estimated at US$440 million and comprises applications in high-value
documents, tax stamps, pharmaceuticals, fuel, and luxury goods.  


    For further information, please contact:
    Oxonica plc                                      01865 856 700
    Kevin Matthews, Chief Executive
    Richard Clarke, Finance Director

    Panmure Gordon                              020 7459 3600
    Hugh Morgan
    Andrew Potts






    Notes to Editors 
    About Oxonica plc - www.oxonica.com
    Oxonica (AIM: OXN.L) is one of the leading international nanomaterials groups with products already launched into international markets
and is listed in London on the AIM market. It was spun-out from Oxford University in 1999. Oxonica's mission is to focus on the development
of innovative commercial solutions for international markets using its expertise in the design and application of nanomaterials. It owns a
portfolio of demand driven products that offer substantial benefits to the target markets of energy, materials, security and diagnostics.
    The Group currently has four operating businesses: Oxonica Energy, Oxonica Materials, Oxonica Security and Oxonica Diagnostics. Oxonica
has already launched products into international markets. Lead products include:
    *                    Envirox* fuel borne catalyst - a catalyst improving fuel economy and reducing emissions
    *                   Optisol* UV absorber - a revolutionary photostable UV protection system designed to optimise
          the performance of quality sunscreens and anti-premature aging products
    Oxonica is also engaged in developing a transformational detection technology that will enable a new generation of rapid, sensitive
tests for the in vitro diagnostic point-of-care testing market. In addition, Oxonica is developing other UV absorber technologies into
polymer systems and coatings, based on similar technologies to that used in Optisol*.


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
MSCLXLFBVLBBFBD

Oxonica (LSE:OXN)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024